Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include the increase in the incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea.

In addition, an increase in R&D activities to develop highly efficient & safe drugs and an upsurge in the use of combination therapies further boost market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the market growth.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/3510

The global cephalosporin market was valued at $3,136 million in 2016 and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8%.

Cephalosporin Market Key Findings:

• Branded cephalosporin segment is expected to register the highest CAGR of 14.4% during the analysis period.

• Injectable cephalosporin is accounted for more than two-fifths share of the global cephalosporin market in 2016.

• Fifth-generation cephalosporin is projected to grow at a CAGR of 15.6% during the forecast period.

• France and Germany collectively contributed to around one-third share of the European cephalosporin market in 2016.

Third-generation cephalosporin segment is expected to dominate the market throughout the analysis period, as these have a broader spectrum of activity. Fifth-generation cephalosporin is expected to register the highest CAGR of 7.6% during the forecast period.

Asia-Pacific is projected to register the highest CAGR of 16.1% during the forecast period, owing to increase in incidence of infectious diseases. In addition, rise in healthcare expenditure is anticipated to offer a lucrative opportunity for the market growth.

Cephalosporin Market Players:

• Lupin Limited
• Merck & Co.
• Allergan Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc

Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3510

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.